Literature DB >> 10749684

Order and maximum incorporation of N-acetyl-D-galactosamine into threonine residues of MUC2 core peptide with microsome fraction of human-colon-carcinoma LS174T cells.

S Iida1, H Takeuchi, K Kato, K Yamamoto, T Irimura.   

Abstract

Mucin 2 (MUC2) is the major intestinal mucin. O-glycans are attached to MUC2 in a potentially diverse arrangement, which is crucial for their interaction with endogeneous and exogeneous lectins. In the present report, five oligopeptides [PTTTPITTTT(K), ITTTTTVTPT(K), TVTPTPTPTG(K), PTPTGTQTPT(K) and TQTPTTTPIT(K)] corresponding to portions of the MUC2 tandem repeat domain were synthesized, and incubated with UDP-N-acetyl-D-galactosamine (UDP-GalNAc) and detergent-soluble microsomes, prepared from the human colon carcinoma cell line LS174T. The products were fractionated by reverse-phase HPLC and characterized by matrix-assisted laser-desorption ionization-time-of-flight mass spectrometry. Oligopeptides with GalNAc residues derived from PTTTPITTTT(K), containing consecutive threonine residues, were found to be glycosylated with 1-7 GalNAc residues per single peptide. The sequences of all glycopeptides were determined. The results indicated that the predominant sites of the first through to the sixth GalNAc incorporation were Thr(3), Thr(6), Thr(5), Thr(2), Thr(4) and Thr(1), respectively. An exception was the presence of a glycopeptide with three GalNAc residues at Thr(1), Thr(4) and Thr(5). Oligopeptides containing alternating threonine residues [TVTPTPTPTG(K) and PTPTGTQTPT(K)] were not fully glycosylated under the same conditions or even after prolonged incubations. Thus, the preferential order and maximum number of GalNAc incorporation into threonine residues of MUC2 core peptides depends on the peptide sequence, when the microsome fraction of LS174T cells is used as a source of N-acetyl-D-galactosaminyltransferases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749684      PMCID: PMC1220987          DOI: 10.1042/0264-6021:3470535

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Binding and internalization of rat colonic mucins by the galactose/N-acetyl-D-galactosamine adherence lectin of Entamoeba histolytica.

Authors:  K Chadee; M L Johnson; E Orozco; W A Petri; J I Ravdin
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

2.  Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism.

Authors:  J R Gum; J C Byrd; J W Hicks; N W Toribara; D T Lamport; Y S Kim
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

Review 3.  Epithelial mucin genes.

Authors:  S J Gendler; A P Spicer
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

4.  Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor.

Authors:  J R Gum; J W Hicks; N W Toribara; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

5.  cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3.

Authors:  E P Bennett; H Hassan; H Clausen
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

6.  Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase.

Authors:  T White; E P Bennett; K Takio; T Sørensen; N Bonding; H Clausen
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

7.  Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.

Authors:  R S Bresalier; J C Byrd; L Wang; A Raz
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

8.  Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat.

Authors:  I Nishimori; N R Johnson; S D Sanderson; F Perini; K Mountjoy; R L Cerny; M L Gross; M A Hollingsworth
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

9.  High affinity binding of the Entamoeba histolytica lectin to polyvalent N-acetylgalactosaminides.

Authors:  P Adler; S J Wood; Y C Lee; R T Lee; W A Petri; R L Schnaar
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

10.  Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen.

Authors:  N Suzuki; K Yamamoto; S Toyoshima; T Osawa; T Irimura
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

View more
  5 in total

1.  IgA1 hinge-region clustered glycan fidelity is established early during semi-ordered glycosylation by GalNAc-T2.

Authors:  Tyler J Stewart; Kazuo Takahashi; Robert H Whitaker; Milan Raska; William J Placzek; Jan Novak; Matthew B Renfrow
Journal:  Glycobiology       Date:  2019-07-01       Impact factor: 4.313

2.  Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.

Authors:  Leslie Revoredo; Shengjun Wang; Eric Paul Bennett; Henrik Clausen; Kelley W Moremen; Donald L Jarvis; Kelly G Ten Hagen; Lawrence A Tabak; Thomas A Gerken
Journal:  Glycobiology       Date:  2015-11-26       Impact factor: 4.313

3.  Quantitative assessment of successive carbohydrate additions to the clustered O-glycosylation sites of IgA1 by glycosyltransferases.

Authors:  Tyler J Stewart; Kazuo Takahashi; Nuo Xu; Amol Prakash; Rhubell Brown; Milan Raska; Matthew B Renfrow; Jan Novak
Journal:  Glycobiology       Date:  2021-06-03       Impact factor: 4.313

Review 4.  MUC1 in carcinoma-host interactions.

Authors:  K Denda-Nagai; T Irimura
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 3.009

5.  Imaging cell surface glycosylation in vivo using "double click" chemistry.

Authors:  André A Neves; Henning Stöckmann; Yelena A Wainman; Joe C-H Kuo; Sarah Fawcett; Finian J Leeper; Kevin M Brindle
Journal:  Bioconjug Chem       Date:  2013-05-16       Impact factor: 4.774

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.